bpc-157 interactions with kratom or mitragynine Refined Prediction of Pharmacokinetic Kratom-Drug Interactions: Time-Dependent Inhibition Considerations Genotoxicity risk assessment of a

Common Injectable Cycle Patterns Approach Conservative start Daily dose 1.0 mg Schedule 5 days on / 2 off Cycle length 4 weeks Approach Standard Daily dose 1.0-1.5 mg Schedule Daily Cycle length 4-6 weeks Approach Higher end Daily dose 1.5-2.0 mg Schedule Daily Cycle length 6-8 weeks Educational reference

Join Laura Young, FDN-P, Board-Certified Holistic Health Practitioner and peptide education specialist*, for a practical, evidence-informed session built for physicians, nurse practitioners, physician assistants, clinic owners, and telehealth teams working in longevity, metabolic health, and hormone optimization

Common (Usually Transient) Side Effects Water retention or puffiness Carpal tunnel-like symptoms Joint stiffness (often temporary) Mild insulin resistance if overdosed How We Monitor Baseline and follow-up IGF-1 levels Body composition changes Symptom tracking and dose titration Our goal is to maintain IGF-1 in the high-normal physiologic range , not to create supraphysiologic levels

L., Whitney, G